:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40010569/1d92f04855922bf13a2b4ee5c2cda922_wm.png)
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodies.
Summary: In a condition called Antiphospholipid Syndrome (APS), the immune system mistakenly attacks a blood protein called β2GPI. Normally, this protein is shaped like a "J" or a circle. However, researchers have discovered that when a specific enzyme called plasmin interacts with β2GPI, it cuts the protein and twists it into a completely new "S" shape. This structural change acts like a beacon, causing the body's harmful antibodies to bind to the protein more aggressively. Understanding this "S" shape helps explain how the disease progresses and why the immune attack is so severe.
Tags
Antiphospholipid Syndrome
Syndrome
Electrophoresis, Polyacrylamide Gel
Electrophoresis
Sulfates
Dynamic Light Scattering
Sodium Dodecyl Sulfate
Fibrinolysin